Kenvue Inc. Common Stock (KVUE)

As the healthcare industry looks toward 2026, Johnson & Johnson (NYSE: JNJ) stands at a historic crossroads, reinforcing its reputation as the ultimate bellwether for the global healthcare sector. On the eve of its official fourth-quarter and full-year 2025 earnings release scheduled for January 21, 2026, the company has already signaled

In a bold move to transcend its identity as a legacy paper commodities giant, Kimberly-Clark (NYSE: KMB) has launched a massive $48.7 billion bid to acquire Kenvue (NYSE: KVUE), the consumer health powerhouse behind iconic brands like Tylenol and Neutrogena. The cash-and-stock deal, which represents one of the largest

As the opening bell approaches on January 21, 2026, all eyes on Wall Street are fixed on Johnson & Johnson (NYSE: JNJ), which is set to report its fourth-quarter and full-year 2025 financial results. This report serves as a critical barometer for the healthcare giant’s first full year as a

Income investors can rely on these stocks.

The global financial markets have emerged from a period of stagnation into what analysts are calling a "Dealmaking Renaissance." In a staggering display of corporate confidence, global mergers and acquisitions (M&A) volume in 2025 surpassed $5.1 trillion, representing a massive 42% year-over-year increase from 2024. This surge has

More than 60 straight years of increasing dividends reflects a strong commitment behind these stocks.

It's time once again for the Market Cap Game Show Holiday Edition, where intuition meets valuation and everyday life meets market caps.

The maker of bathroom products is about to undergo a significant change in its business.

It's not too late to reshape and optimize your portfolio for what could be a very different market environment than last year's.

With yields over 4%, these dividend stocks are great buys for income investors in the new year.

As the calendar turns to January 6, 2026, the global financial landscape is witnessing a dramatic resurgence in corporate dealmaking that has effectively ended the "deal desert" of the early 2020s. Led by a revitalized Morgan Stanley (NYSE: MS), major investment banks are entering the new year with pipelines at

These companies pay high-yielding and steadily rising dividends.

In a move that has sent shockwaves through the retail sector as the new year begins, Toms Capital Investment Management (TCIM), the activist hedge fund led by billionaire Noam Gottesman, has revealed a significant stake in Target Corporation (NYSE:TGT). The investment, finalized in the closing days of 2025, arrives

These companies pay steadily rising dividends.

As 2025 draws to a close, the consumer staples sector is witnessing one of its most dramatic transformations in decades. The recent announcement that Kimberly-Clark (NYSE:KMB) will acquire Kenvue (NYSE:KVUE) in a deal valued at approximately $48.7 billion has sent shockwaves through the market, but it is

Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.